Ildstad Suzanne's Form 4 filing
Tourmaline Bio, Inc. (TRML) · filed Jun 14, 2023
- Accession no.
- 0001209191-23-037183
- Filed
- Jun 14, 2023
- Trade date
- Jun 12-14, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $112.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ildstad SuzanneCIK 0001845822 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2023 | Common Stock | SSaleDisposed | −16,870 | $2.59 | −$43,693.3 | 3,798,542 | Direct | |
| Jun 13, 2023 | Common Stock | SSaleDisposed | −14,208 | $2.56 | −$36,372.48 | 3,784,334 | Direct | |
| Jun 14, 2023 | Common Stock | SSaleDisposed | −12,942 | $2.49 | −$32,225.58 | 3,771,392 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2023 | Common Stock | AGrant or awardAcquired | +20,500 | $0.00 | $0 | 20,500 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.